Key result
Echocardiographic strain analysis reveals early myocardial dysfunction in Chagas patients lacking detectable fibrosis.
Why the study?
Does echocardiographic strain analysis correlate with cardiac magnetic resonance fibrosis assessment in adults with Chagas cardiomyopathy?
Cross-Sectional (n=79)
Does echocardiographic strain analysis correlate with cardiac magnetic resonance fibrosis assessment in adults with Chagas cardiomyopathy?
Effect estimate: mean AUC 0.72
Strain imaging can detect early myocardial dysfunction in Chagas disease before fibrosis is visible on CMR, but its clinical utility is limited by weak correlation with fibrosis burden and high inter-vendor variability.
May enable earlier Chagas detection than CMR; leaves open routine adoption pending inter-vendor standardization.
AIM: Chagas cardiomyopathy (CC) is characterized by progressive myocardial fibrosis, contractile dysfunction, and structural remodeling. Strain imaging (SI) holds promise for detecting early myocardial impairment, but its utility in tracking CC progression remains unclear. This study evaluated SI's clinical utility across the CC spectrum. METHODS AND RESULTS: In this cross-sectional study, 79 adults with serologically confirmed Chagas disease underwent myocardial strain assessment using equipment from General Electric (GE) or Philips (PH). Strain parameters, including global longitudinal strain (GLS), and segmental longitudinal strain (SLS), were analyzed across four CC stages (A, B1, B2, and C), stratified by fibrosis severity via late gadolinium enhancement (LGE) on cardiac magnetic resonance. Spearman coefficients assessed correlations between strain and fibrosis burden. Lin's concordance index evaluated inter-vendor agreement. Diagnostic performance for fibrosis detection was quantified using area under the receiver operating characteristic curve (AUC), with strain abnormalities defined by ROC-derived median cut-offs. GLS declined progressively with advancing CC stage across both vendors, though correlations with fibrosis percentage were weak (ρ < 0.30). SLS abnormalities were present in Stage A patients despite absence of LGE-detected fibrosis. SLS showed moderate accuracy in localizing, but not quantifying, fibrosis (mean AUC: 0.72 ± 0.11). Inter-vendor concordance was limited for GLS (Lin's index: 0.80) and SLS (range: 0.20-0.70). CONCLUSIONS: SI reveals early myocardial dysfunction in Chagas patients, even in the absence of detectable fibrosis, suggesting a subclinical continuum of disease. However, the modest correlation with fibrosis burden and substantial inter-vendor variability underscore the need for vendor-specific calibration and caution in clinical interpretation.
No takes yet. Share an insight, caveat, or question.
Romero-Acero et al. (2026) conducted a cross-sectional in Chagas cardiomyopathy (n=79). Strain imaging vs. Cardiac magnetic resonance with late gadolinium enhancement was evaluated on Diagnostic performance for fibrosis detection and correlation with fibrosis burden (mean AUC 0.72). Strain imaging revealed early myocardial dysfunction without detectable fibrosis, with segmental longitudinal strain showing moderate accuracy for localizing fibrosis (mean AUC 0.72 ± 0.11).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: